CYTOKINETICS INC - COMMON STOCK (CYTK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CYTK on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
119,358,581
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
140,918,559
Holdings value
$7,744,283,008
% of all portfolios
0.01%
Number of holders
376
Number of buys
222
Number of sells
-127
Average buys %
+0.01%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CYTOKINETICS INC - COMMON STOCK (CYTK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 16% +8.7% $1,049,591,620 +$82,161,518 19,097,373 +8.5% T. Rowe Price Investment Management, Inc. 30 Sep 2025
FMR LLC 10.9% +17% $479,911,470 +$71,598,573 13,101,596 +18% FMR LLC 31 Jul 2025
VANGUARD GROUP INC 10.09% $480,565,061 11,915,821 The Vanguard Group 31 Dec 2024
STATE STREET CORP 4.7% $308,728,677 5,617,334 STATE STREET CORPORATION 30 Sep 2025

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 140,918,559 $7,744,283,008 +$248,284,955 $54.96 376
2025 Q2 137,672,960 $4,548,776,123 +$22,757,186 $33.04 308
2025 Q1 134,841,578 $5,424,137,644 +$124,956,259 $40.19 352
2024 Q4 131,310,237 $6,182,701,180 -$305,419,938 $47.04 342
2024 Q3 135,965,538 $7,179,495,863 -$22,095,980 $52.8 343
2024 Q2 135,538,659 $7,341,546,249 +$905,298,022 $54.18 341
2024 Q1 117,698,153 $8,252,737,252 +$191,436,420 $70.11 385
2023 Q4 114,281,648 $9,541,763,681 +$330,415,688 $83.49 344
2023 Q3 109,279,375 $3,219,564,491 +$24,845,219 $29.46 248
2023 Q2 108,724,328 $3,548,383,679 -$11,513,808 $32.62 252
2023 Q1 108,867,212 $3,829,923,005 +$81,444,143 $35.19 259
2022 Q4 106,503,991 $4,877,881,469 +$56,105,064 $45.82 271
2022 Q3 104,802,748 $5,076,619,614 -$48,250,542 $48.45 271
2022 Q2 105,856,945 $4,159,716,153 +$425,134,262 $39.29 255
2022 Q1 95,536,900 $3,516,647,768 +$153,742,395 $36.81 233
2021 Q4 91,314,688 $4,159,253,639 +$41,291,377 $45.58 244
2021 Q3 90,207,271 $3,220,707,699 +$496,552,275 $35.74 208
2021 Q2 75,530,208 $1,494,840,686 +$7,258,934 $19.79 184
2021 Q1 74,824,822 $1,739,406,944 +$58,909,832 $23.26 185
2020 Q4 72,927,397 $1,515,101,565 +$2,994,280 $20.78 174
2020 Q3 68,793,341 $1,486,919,340 +$223,796,678 $21.65 176
2020 Q2 57,902,469 $1,364,739,639 +$106,180,554 $23.57 155
2020 Q1 55,577,469 $655,114,415 +$7,494,589 $11.79 140
2019 Q4 54,967,200 $583,186,084 +$110,961,493 $10.61 138
2019 Q3 44,469,174 $506,043,282 +$8,118,835 $11.38 142
2019 Q2 43,758,616 $492,255,849 +$60,765,739 $11.25 131
2019 Q1 39,149,048 $316,789,384 +$2,575,674 $8.09 128
2018 Q4 39,751,282 $251,199,067 +$585,312 $6.32 125
2018 Q3 38,573,613 $379,945,234 +$12,021,170 $9.85 115
2018 Q2 37,497,804 $311,245,360 +$6,016,664 $8.3 122
2018 Q1 36,846,990 $265,290,511 -$12,323,363 $7.2 120
2017 Q4 38,427,550 $313,274,680 -$31,796,309 $8.15 127
2017 Q3 39,538,270 $573,258,785 +$22,292,833 $14.5 128
2017 Q2 38,242,269 $462,840,533 +$119,794,762 $12.1 135
2017 Q1 28,322,853 $363,941,426 +$63,505,651 $12.85 105
2016 Q4 26,441,374 $321,178,146 -$2,239,851 $12.15 99
2016 Q3 26,660,084 $244,743,898 +$491,452 $9.18 88
2016 Q2 26,539,822 $251,857,889 +$5,257,399 $9.49 93
2016 Q1 26,628,683 $187,563,987 -$4,719,516 $7.05 105
2015 Q4 26,471,070 $276,904,125 +$56,009,005 $10.46 124
2015 Q3 21,585,148 $144,504,660 +$5,042,983 $6.69 102
2015 Q2 20,750,403 $139,436,627 +$7,715,400 $6.72 96
2015 Q1 19,599,208 $133,005,626 +$956,806 $6.78 92
2014 Q4 19,305,123 $154,537,250 +$202,262 $8.01 84
2014 Q3 19,810,554 $69,719,049 -$7,580,787 $3.52 82
2014 Q2 21,028,918 $100,514,515 -$36,406,249 $4.78 84
2014 Q1 22,477,638 $213,590,026 +$39,204,449 $9.5 104